image
Beam Therapeutics Inc. BEAM
Healthcare - Biotechnology - NASDAQ - US
Watchlist
$ 24.05
-8.59 %
$ 1.99 B
Market Cap
-15.22
P/E
INCOME STATEMENT
378 M REVENUE
520.01%
Growth Rates
1Year 520.01%
3Years 2406.01%
5Years 0.00%
7Years 0.00%
10Years 0.00%
-176 M OPERATING INCOME
47.86%
Growth Rates
1Year 47.86%
3Years -9.95%
5Years -31.00%
7Years 0.00%
10Years 0.00%
-133 M NET INCOME
54.16%
Growth Rates
1Year 54.16%
3Years 12.02%
5Years -2.57%
7Years 0.00%
10Years 0.00%
EFFICIENCY
Earnings Waterfall Beam Therapeutics Inc.
image
Revenue 378 M
Cost Of Revenue 437 M
Gross Profit -59.7 M
Operating Expenses 554 M
Operating Income -176 M
Other Expenses -44 M
Net Income -133 M

Income Statement

Millions
Dec-2023 Dec-2022 Dec-2021 Dec-2020 Dec-2019 Dec-2018 Dec-2017
REVENUE
Revenue 377.7 60.9 51.8 24 K 18 K 0 0
GROSS PROFIT
Cost Of Revenue 437.4 22.6 16.4 103.2 5.4 0.7 11 K
Gross Profit (59.7) 38.3 35.4 (103.2) (5.4) (0.7) 11 K
OPERATING INCOME
Operating Expenses 554.2 399.4 444.3 132.8 75.2 45.7 7.9
Selling, General and Administrative Expenses 116.8 87.8 57.2 29.6 20.6 11.9 2.0
Research and Development Expenses 437.4 311.6 387.1 103.2 54.6 33.9 5.9
Operating Income (176.5) (338.5) (392.5) (132.8) (75.2) (45.7) (7.9)
PRE-TAX INCOME
Interest Income Expense 0 15.3 9 K 1.6 0.2 0 0
Total Other Income 45.3 78.3 21.8 (61.8) (3.2) (71.0) (0.1)
Pre-Tax Income (131.2) (260.2) (370.6) (194.6) (78.3) (116.7) (8.0)
NET INCOME
Tax Provision 1.4 3.4 (29.3) 61.8 0.1 (71.0) 0.5
Net Income (132.5) (263.6) (341.4) (256.4) (78.4) (115.3) (8.0)
EPS 1.72 3.76 5.31 5.49 1.53 3.28 0.62